CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD

Part of paid clinical trials in Chicago, Illinois.

Sponsor
University of Illinois at Chicago
Study ID
NCT07210710
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • CKD Awareness, Referrals, Education, and Support (CARES) — BEHAVIORAL
    We will target diabetic patients eligible for an early-stage CKD diagnosis with a nurse-delivered, pre-PCP-visit 1:1 virtual session including 1) tailored, evidence-based CKD education 2) motivational interviewing with self-management goal setting, and 3) social determinants of health screening with referrals to services as needed.
  • Attention control — BEHAVIORAL
    The control group will receive an attention control session of general education about diabetes-related health behaviors (e.g., diet and physical activity) that does not refer to CKD, based on American Diabetes Association materials.

Study Details

The goal of this pilot clinical trial is to learn if an intervention delivering education, motivational support, and social support can prevent worsening kidney disease in adults with diabetes and early-stage kidney disease. The main questions it aims to answer are: 1. Is this intervention feasible to deliver and acceptable to patients? 2. What is the impact of the intervention on patient motivation, self-efficacy, kidney disease knowledge, and use of support services referrals? The investigators will compare information collected about participants' response to this intervention with a group of similar patients who receive general diabetes information. Participants will meet virtually with a nurse approximately 1 week before a scheduled primary care provider visit and complete surveys over the phone three times in a period of three months.

Key Dates

First listed
Oct 7, 2025
Start date
Nov 15, 2025
Status verified
Aug 2026
Primary completion
Dec 30, 2026
Completion
Jul 31, 2027

Study Design

Enrollment
50 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention group
    Participants will participate in a nurse-led virtual session delivering education about chronic kidney disease, motivational interviewing to set a self-management goal, and screening/referral for social determinants of health barriers to treatment adherence and engagement.
  • Active Comparator: Control group
    The attention control group will participate in a nurse-led virtual session delivering general information about diabetes and treatment.

Primary Outcome Measure

Motivation for diabetes-related self-care behaviour scale [ Time Frame: From enrollment to study completion (2-3 months) ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Illinois Chicago HospitalChicagoIllinois60612
Eleanor Rivera Study PI
[email protected]
312-996-7972

Find similar trials in Chicago, IL

Nationwide
Chronic kidney disease trialsNephrology trialsKidney disease trials
By condition
Chronic kidney disease
By specialty
NephrologyKidney disease
By research site
University of Illinois Chicago Hospital· Chicago, IL

Related Studies